Skip to content

Effectiveness of Topical creams in reducing knee pain: a double-blinded randomised study

Effectiveness of Topical creams in reducing knee pain: a double-blinded randomised study

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619001299190
Enrollment
100
Registered
2019-09-20
Start date
2019-10-14
Completion date
2019-10-14
Last updated
2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The use of compounded topical pain creams to reduce pain and inflammation has increased dramatically, yet their effectiveness has not been well evaluated. This study compares the efficacy of two topical compound cream in reducing acute postoperative and/or chronic arthritic knee pain. In this double-blind, randomised study we examine two topical creams; Ketoprofen 10% only verses a compound cream (Ketoprofen 10% plus amitriptyline 5%, gabapentin 5%) applied twice a day. Findings of this study will identify which compound combination is more superior in reducing the knee pain in of 2 clinical populations 1) those experiencing postoperative knee pain; and 2) arthritic knee pain.

Interventions

Compound cream ingredients Ketoprofen 10%, amitriptyline 5%, and gabapentin 5% (Cream C) 4mL measured by an actuated pump twice daily applied to the knee for 4 weeks. Remaining product will be weighed at the end of the 4 weeks to gauge adherence.

Sponsors

The Joint Studio
Lead SponsorOther Collaborative groups

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Inclusion: 1. The individual has signed a Patient Informed Consent (PIC) specific to this study, and approved by the Institutional Ethics Review Board. 2. The individual is between 18 and 80 years of age. 3. The individual clinically presents with Grade 2 or higher osteoarthritis of the knee OR has undergone uncomplicated primary TKR in the previous 2 weeks.

Exclusion criteria

Exclusion: 1. Persistent opioid medication use > 3 months 2. Is pregnant or planning to become pregnant 3. Surgical invention planned in < 2 months 4. Comorbidities of complex pain disorder or severe mobility compromise (eg. complex regional pain syndrome, severe back pain, gout, multiple sclerosis, muscular mystrophy, Parkinson’s disease, morbidly obese, hemiplegic). 5. Known allergy to egg, or ketoprofen 6. Taking blood thinners eg. warfarin, apixaban, ticagrelor, rivaroxaoba, dabigatran 7. The individual is a prisoner, physically or mentally compromised, is unwilling or unable to comply with scheduled evaluations and/or treatment (eg. Vegan unwilling to use egg-based conduit)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026